nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Alzheimer’s Association Update for July 2012
|
|
|
2012 |
8 |
4 |
p. 376-377 2 p. |
artikel |
2 |
Biomarker development: A population-level perspective
|
Khachaturian, Ara S. |
|
2012 |
8 |
4 |
p. 247-249 3 p. |
artikel |
3 |
Cardiovascular fitness is associated with altered cortical glucose metabolism during working memory in ε4 carriers
|
Deeny, Sean P. |
|
2012 |
8 |
4 |
p. 352-356 5 p. |
artikel |
4 |
Clinical and neurobiological correlates of soluble amyloid precursor proteins in the cerebrospinal fluid
|
Alexopoulos, Panagiotis |
|
2012 |
8 |
4 |
p. 304-311 8 p. |
artikel |
5 |
Common Alzheimer’s Disease Research Ontology: National Institute on Aging and Alzheimer’s Association Collaborative Project
|
Refolo, Lorenzo M. |
|
2012 |
8 |
4 |
p. 372-375 4 p. |
artikel |
6 |
Contents
|
|
|
2012 |
8 |
4 |
p. A1-A2 nvt p. |
artikel |
7 |
Development of biomarkers to chart all Alzheimer’s disease stages: The royal road to cutting the therapeutic Gordian Knot
|
Hampel, Harald |
|
2012 |
8 |
4 |
p. 312-336 25 p. |
artikel |
8 |
Editorial Board
|
|
|
2012 |
8 |
4 |
p. A4- 1 p. |
artikel |
9 |
Effect of human cerebrospinal fluid sampling frequency on amyloid-β levels
|
Li, Jinhe |
|
2012 |
8 |
4 |
p. 295-303 9 p. |
artikel |
10 |
Effects of n-3 fatty acids on cognitive decline: A randomized, double-blind, placebo-controlled trial in stable myocardial infarction patients
|
Geleijnse, Johanna M. |
|
2012 |
8 |
4 |
p. 278-287 10 p. |
artikel |
11 |
Gaining precision on the Alzheimer’s Disease Assessment Scale-cognitive: A comparison of item response theory-based scores and total scores
|
Balsis, Steve |
|
2012 |
8 |
4 |
p. 288-294 7 p. |
artikel |
12 |
Improved protocol for measurement of plasma β-amyloid in longitudinal evaluation of Alzheimer’s Disease Neuroimaging Initiative study patients
|
Figurski, Michal J. |
|
2012 |
8 |
4 |
p. 250-260 11 p. |
artikel |
13 |
Leptin and dementia over 32 years—The Prospective Population Study of Women
|
Gustafson, Deborah R. |
|
2012 |
8 |
4 |
p. 272-277 6 p. |
artikel |
14 |
Medical and Scientific Advisory Council
|
|
|
2012 |
8 |
4 |
p. A5- 1 p. |
artikel |
15 |
Safety and biomarker effects of solanezumab in patients with Alzheimer’s disease
|
Farlow, Martin |
|
2012 |
8 |
4 |
p. 261-271 11 p. |
artikel |
16 |
Some evolutionary perspectives on Alzheimer’s disease pathogenesis and pathology
|
Glass, Daniel J. |
|
2012 |
8 |
4 |
p. 343-351 9 p. |
artikel |
17 |
Subscriber information
|
|
|
2012 |
8 |
4 |
p. A6- 1 p. |
artikel |
18 |
Workgroup on NAPA's scientific agenda for a national initiative on Alzheimer’s disease
|
|
|
2012 |
8 |
4 |
p. 357-371 15 p. |
artikel |
19 |
Worldwide Alzheimer’s Disease Neuroimaging Initiative
|
Carrillo, Maria C. |
|
2012 |
8 |
4 |
p. 337-342 6 p. |
artikel |